Franca Bianchi Selected Research

Uncoupling Protein 2

5/2022	Role of Uncoupling Protein 2 Gene Polymorphisms on the Risk of Ischemic Stroke in a Sardinian Population.
1/2022	Uncoupling Protein 2 as a Pathogenic Determinant and Therapeutic Target in Cardiovascular and Metabolic Diseases.
10/2021	An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation.
6/2020	Brain Overexpression of Uncoupling Protein-2 (UCP2) Delays Renal Damage and Stroke Occurrence in Stroke-Prone Spontaneously Hypertensive Rats.
1/2017	A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.
2/2013	Differential modulation of uncoupling protein 2 in kidneys of stroke-prone spontaneously hypertensive rats under high-salt/low-potassium diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franca Bianchi Research Topics

Disease

14	Stroke (Strokes) 01/2022 - 02/2013
7	Hypertension (High Blood Pressure) 01/2022 - 08/2015
4	Acute Coronary Syndrome 01/2022 - 04/2016
3	Myocardial Infarction 11/2021 - 08/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 04/2016
3	Inflammation (Inflammations) 01/2017 - 02/2013
2	Ischemic Stroke 05/2022 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2017
2	Stable Angina 01/2019 - 04/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2018 - 08/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2016 - 04/2016
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Atherosclerosis 11/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Vascular Diseases (Vascular Disease) 10/2021
1	Atrial Fibrillation 01/2021
1	Cardiomyopathies (Cardiomyopathy) 12/2020
1	Dementia (Dementias) 07/2020
1	Pathologic Processes 07/2020
1	Cognitive Dysfunction 07/2020
1	Mitral Valve Insufficiency (Mitral Regurgitation) 05/2020
1	Proteinuria 01/2018
1	Infarction (Infarctions) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017
1	ST Elevation Myocardial Infarction 08/2016
1	Unstable Angina 08/2016
1	Hypercholesterolemia 08/2016
1	Necrosis 02/2013
1	Vascular System Injuries 02/2013

Drug/Important Bio-Agent (IBA)

7	SaltsIBA 11/2021 - 02/2013
6	Uncoupling Protein 2IBA 05/2022 - 02/2013
6	Proteins (Proteins, Gene)FDA Link 06/2020 - 02/2013
4	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 08/2016
4	Natriuretic PeptidesIBA 07/2020 - 04/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 02/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2015
3	AntioxidantsIBA 01/2019 - 02/2013
3	PotassiumIBA 01/2017 - 02/2013
2	TrehaloseIBA 11/2021 - 01/2018
2	DisaccharidesIBA 11/2021 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 07/2020 - 04/2016
2	Beclin-1IBA 01/2020 - 01/2018
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2020 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 01/2017 - 02/2016
2	SodiumIBA 01/2017 - 07/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	CalciumIBA 01/2022
1	Stromal Interaction Molecule 1IBA 01/2022
1	LipidsIBA 04/2021
1	SphingolipidsIBA 04/2021
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 12/2020
1	Antihypertensive Agents (Antihypertensives)IBA 12/2020
1	Nicotinamide MononucleotideIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2020
1	erucylphosphocholineIBA 01/2020
1	ThymineIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Sucrose (Saccharose)IBA 01/2018
1	Neprilysin (Neutral Endopeptidase)IBA 01/2018
1	Valsartan (Vals)FDA Link 01/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2018
1	Type 1 Angiotensin ReceptorIBA 01/2018
1	Fenofibrate (CiL)FDA LinkGeneric 01/2017
1	AnionsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Sirtuin 1IBA 08/2015
1	MicroRNAs (MicroRNA)IBA 02/2013

Therapy/Procedure

2	Therapeutics 12/2020 - 02/2018
2	Percutaneous Coronary Intervention 02/2018 - 04/2016
1	Stents 04/2016